Commentary: The Place of Tenofovir Disoproxil Fumarate in Pediatric Antiretroviral Therapy

被引：2
|
作者：
Havens, Peter L. [1 ]
Hazra, Rohan [2 ]
机构：
[1] Med Coll Wisconsin, Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA
[2] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2015年 / 34卷 / 04期
关键词：
HIV-INFECTED CHILDREN; SAFETY; PHARMACOKINETICS; EMTRICITABINE; ZIDOVUDINE; LAMIVUDINE; EFAVIRENZ; EFFICACY; REGIMEN;
D O I：
10.1097/INF.0000000000000650
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：406 / 408
页数：3
相关论文
共 50 条
  • [21] The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis
    Wang, Huilian
    Lu, Xi
    Yang, Xudong
    Xu, Nan
    MEDICINE, 2016, 95 (41)
  • [22] Tenofovir disoproxil fumarate: profile report
    Tony Antoniou
    Anil Kumar
    Drugs & Therapy Perspectives, 2004, 20 (3) : 4 - 6
  • [23] Toxicological evaluation of antiretroviral Tenofovir Disoproxil Fumarate on the mollusk Biomphalaria glabrata and its hemocytes
    Souza-Silva, Gabriel
    Souza, Clessius Ribeiro
    Pereira, Cintia Aparecida de Jesus
    Lima, Walter dos Santos
    Mol, Marcos Paulo Gomes
    Silveira, Micheline Rosa
    SCIENCE OF THE TOTAL ENVIRONMENT, 2023, 891
  • [24] Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy
    Nishijima, Takeshi
    Kurosawa, Takuma
    Tanaka, Noriko
    Kawasaki, Yohei
    Kikuchi, Yoshimi
    Oka, Shinichi
    Gatanaga, Hiroyuki
    AIDS, 2016, 30 (10) : 1563 - 1571
  • [25] Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects
    Lee, Sangmi
    Kim, Eunwoo
    Moon, Seol Ju
    Jung, Jina
    Lee, SeungHwan
    Yu, Kyung-Sang
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (01) : 45 - 52
  • [26] Efficacy and Safety of Dolutegravir With Emtricitabine and Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate, and Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate HIV Antiretroviral Therapy Regimens Started in Pregnancy oIMPAACT 2010/VESTEDTHORN: A Multicentre, Open-label, Randomised, Controlled, Phase 3 Trial
    Aquino, Marcella
    PEDIATRICS, 2021, 148 : S70 - S70
  • [27] Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy
    Biagi, Mark
    Badowski, Melissa
    Chiampas, Thomas
    Young, Jeremy
    Vaughn, Pyrai
    Shicker, Louis
    Patel, Mahesh
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (09) : 808 - 811
  • [28] Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
    Lockman, Shahin
    Brummel, Sean S.
    Ziemba, Lauren
    Stranix-Chibanda, Lynda
    McCarthy, Katie
    Coletti, Anne
    Jean-Philippe, Patrick
    Johnston, Ben
    Krotje, Chelsea
    Fairlie, Lee
    Hoffman, Risa M.
    Sax, Paul E.
    Moyo, Sikhulile
    Chakhtoura, Nahida
    Stringer, Jeffrey S. A.
    Masheto, Gaerolwe
    Korutaro, Violet
    Cassim, Haseena
    Mmbaga, Blandina T.
    Joao, Esau
    Hanley, Sherika
    Purdue, Lynette
    Holmes, Lewis B.
    Momper, Jeremiah D.
    Shapiro, Roger L.
    Thoofer, Navdeep K.
    Rooney, James F.
    Frenkel, Lisa M.
    Amico, K. Rivet
    Chinula, Lameck
    Currier, Judith
    LANCET, 2021, 397 (10281): : 1276 - 1292
  • [29] Renal outcomes in patients initiated on tenofovir disoproxil fumarate-based antiretroviral therapy at a community health centre in Malawi
    Chikwapulo, Bongani
    Ngwira, Bagrey
    Sagno, Jean Baptiste
    Evans, Rhys
    INTERNATIONAL JOURNAL OF STD & AIDS, 2018, 29 (07) : 650 - 657
  • [30] Weight and body mass index increase after switch from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate-containing treatment in an antiretroviral therapy-experienced group
    Lomiak, Michal
    Stepnicki, Jan
    Mikula, Tomasz
    Wiercinska-Drapalo, Alicja
    INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (06) : 570 - 577
12345